Modulation of pentose phosphate pathway during cell cycle progression in human colon adenocarcinoma cell line HT29
Pedro Vizán
Department of Biochemistry and Molecular Biology, Institute of Biomedicine of University of Barcelona (IBUB), Barcelona, Spain
Search for more papers by this authorGema Alcarraz-Vizán
Department of Biochemistry and Molecular Biology, Institute of Biomedicine of University of Barcelona (IBUB), Barcelona, Spain
Search for more papers by this authorSantiago Díaz-Moralli
Department of Biochemistry and Molecular Biology, Institute of Biomedicine of University of Barcelona (IBUB), Barcelona, Spain
Search for more papers by this authorOlga N. Solovjeva
A. N. Belozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, Russia
Search for more papers by this authorWilma M. Frederiks
Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Search for more papers by this authorCorresponding Author
Marta Cascante
Department of Biochemistry and Molecular Biology, Institute of Biomedicine of University of Barcelona (IBUB), Barcelona, Spain
Fax: 34-934021219.
Department of Biochemistry and Molecular Biology, Faculty of Biology (Edifici nou), University of Barcelona, Av Diagonal 645 08028 Barcelona, SpainSearch for more papers by this authorPedro Vizán
Department of Biochemistry and Molecular Biology, Institute of Biomedicine of University of Barcelona (IBUB), Barcelona, Spain
Search for more papers by this authorGema Alcarraz-Vizán
Department of Biochemistry and Molecular Biology, Institute of Biomedicine of University of Barcelona (IBUB), Barcelona, Spain
Search for more papers by this authorSantiago Díaz-Moralli
Department of Biochemistry and Molecular Biology, Institute of Biomedicine of University of Barcelona (IBUB), Barcelona, Spain
Search for more papers by this authorOlga N. Solovjeva
A. N. Belozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, Russia
Search for more papers by this authorWilma M. Frederiks
Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Search for more papers by this authorCorresponding Author
Marta Cascante
Department of Biochemistry and Molecular Biology, Institute of Biomedicine of University of Barcelona (IBUB), Barcelona, Spain
Fax: 34-934021219.
Department of Biochemistry and Molecular Biology, Faculty of Biology (Edifici nou), University of Barcelona, Av Diagonal 645 08028 Barcelona, SpainSearch for more papers by this authorAbstract
Cell cycle regulation is dependent on multiple cellular and molecular events. Cell proliferation requires metabolic sources for the duplication of DNA and cell size. However, nucleotide reservoirs are not sufficient to support cell duplication and, therefore, biosynthetic pathways should be upregulated during cell cycle. Here, we reveal that glucose-6-phosphate dehydrogenase (G6PDH) and transketolase (TKT), the 2 key enzymes of oxidative and nonoxidative branches of the pentose phosphate pathway (PPP), respectively, which is necessary for nucleotide synthesis, are enhanced during cell cycle progression of the human colon cancer cell line HT29. These enhanced enzyme activities coincide with an increased ratio of pentose monophosphate to hexose monophosphate pool during late G1 and S phase, suggesting a potential role for pentose phosphates in proliferating signaling. Isotopomeric analysis distribution of nucleotide ribose synthesized from 1,2-13C2-glucose confirms the activation of the PPP during late G1 and S phase and reveals specific upregulation of the oxidative branch. Our data sustain the idea of a critical oxidative and nonoxidative balance in cancer cells, which is consistent with a late G1 metabolic check point. The distinctive modulation of these enzymes during cell cycle progression may represent a new strategy to inhibit proliferation in anticancer treatments. © 2009 UICC
References
- 1 Malumbres M,Barbacid M. Is cyclin D1-CDK4 kinase a bona fide cancer target? Cancer Cell 2006; 9: 2–4.
- 2 Shapiro GI. Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol 2006; 24: 1770–83.
- 3
Bartek J,Lukas J,Bartkova J.
Perspective: defects in cell cycle control and cancer.
J Pathol
1999;
187:
95–9.
10.1002/(SICI)1096-9896(199901)187:1<95::AID-PATH249>3.0.CO;2-# CAS PubMed Web of Science® Google Scholar
- 4 Hanahan D,Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57–70.
- 5 Vizán P,Mazurek S,Cascante M. Robust metabolic adaptation underlying tumor progression. Metabolomics 2008; 4: 1–12.
- 6 Jones RG,Plas DR,Kubek S,Buzzai M,Mu J,Xu Y,Birnbaum MJ,Thompson CB. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 2005; 18: 283–93.
- 7 Bui T,Thompson CB. Cancer's sweet tooth. Cancer Cell 2006; 9: 419–20.
- 8 Pfeiffer T,Schuster S,Bonhoeffer S. Cooperation and competition in the evolution of ATP-producing pathways. Science 2001; 292: 504–7.
- 9 Swinnen JV,Brusselmans K,Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 2006; 9: 358–65.
- 10 Cascante M,Centelles JJ,Veech RL,Lee WN,Boros LG. Role of thiamin (vitamin B-1) and transketolase in tumor cell proliferation. Nutr Cancer 2000; 36: 150–4.
- 11 Eigenbrodt E,Fister P,Reinacher M. New perspectives on carbohydrate metabolism in tumor cells. In: R Beitner, ed. Regulation of carbohydrate metabolism. Florida: CRC Press, 1985.
- 12 Gunsalus IC,Horecker BL,Wood WA. Pathways of carbohydrate metabolism in microorganisms. Bacteriol Rev 1955; 19: 79–128.
- 13 Horecker BL. The pentose phosphate pathway. J Biol Chem 2002; 277: 47965–71.
- 14 Boros LG,Lee PWN,Brandes JL,Cascante M,Muscarella P,Schirmer WJ,Melvin WS,Ellison EC. Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism? Med Hypotheses 1998; 50: 55–9.
- 15 Boren J,Montoya AR,de Atauri P,Comin-Anduix B,Cortes A,Centelles JJ,Frederiks WM,Van Noorden CJ,Cascante M. Metabolic control analysis aimed at the ribose synthesis pathways of tumor cells: a new strategy for antitumor drug development. Mol Biol Rep 2002; 29: 7–12.
- 16 Tian WN,Braunstein LD,Pang J,Stuhlmeier KM,Xi QC,Tian X,Stanton RC. Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J Biol Chem 1998; 273: 10609–17.
- 17 Schenk G,Duggleby RG,Nixon PF. Heterologous expression of human transketolase. Int J Biochem Cell Biol 1998; 30: 369–78.
- 18 Hu LH,Yang JH,Zhang DT,Zhang S,Wang L,Cai PC,Zheng JF,Huang JS. The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells. Anticancer Drugs 2007; 18: 427–33.
- 19 Langbein S,Zerilli M,Zur Hausen A,Staiger W,Rensch-Boschert K,Lukan N,Popa J,Ternullo MP,Steidler A,Weiss C,Grobholz R,Willeke F, et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br J Cancer 2006; 94: 578–85.
- 20 Staiger WI,Coy JF,Grobholz R,Hofheinz RD,Lukan N,Post S,Schwarzbach MH,Willeke F. Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer. Oncol Rep 2006; 16: 657–61.
- 21 Langbein S,Frederiks WM,Hausen AZ,Popa J,Lehmann J,Weiss C,Alken P,Coy JF. Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer. Int J Cancer 2008; 122: 2422–8.
- 22 Krockenberger M,Honig A,Rieger L,Coy JF,Sutterlin M,Kapp M,Horn E,Dietl J,Kammerer U. Transketolase-like 1 expression correlates with subtypes of ovarian cancer and the presence of distant metastases. Int J Gynecol Cancer 2007; 17: 101–6.
- 23 Purcell WT,Ettinger DS. Novel antifolate drugs. Curr Oncol Rep 2003; 5: 114–25.
- 24 Boros LG,Puigjaner J,Cascante M,Lee WN,Brandes JL,Bassilian S,Yusuf FI,Williams RD,Muscarella P,Melvin WS,Schirmer WJ. Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res 1997; 57: 4242–8.
- 25 Rais B,Comin B,Puigjaner J,Brandes JL,Creppy E,Saboureau D,Ennamany R,Paul Lee W-N,Boros LG,Cascante M. Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle. FEBS Lett 1999; 456: 113–18.
- 26 Ramos-Montoya A,Lee WN,Bassilian S,Lim S,Trebukhina RV,Kazhyna MV,Ciudad CJ,Noe V,Centelles JJ,Cascante M. Pentose phosphate cycle oxidative and nonoxidative balance: a new vulnerable target for overcoming drug resistance in cancer. Int J Cancer 2006; 119: 2733–41.
- 27 Matito C,Mastorakou F,Centelles JJ,Torres JL,Cascante M. Antiproliferative effect of antioxidant polyphenols from grape in murine Hepa-1c1c7. Eur J Nutr 2003; 42: 43–9.
- 28 Smeets EH,Muller H,de Wael J. A NADH-dependent transketolase assay in erythrocyte hemolysates. Clin Chim Acta 1971; 33: 379–86.
- 29 Van Noorden CJF,Frederiks WM. Enzyme histochemistry: a laboratory manual of current methods. Oxford: Oxford University Press, 1992.
- 30 Butcher RG,Van Noorden CJ. Reaction rate studies of glucose-6-phosphate dehydrogenase activity in sections of rat liver using four tetrazolium salts. Histochem J 1985; 17: 993–1008.
- 31 Van Noorden CJ,Butcher RG. Histochemical localization of NADP-dependent dehydrogenase activity with four different tetrazolium salts. J Histochem Cytochem 1984; 32: 998–1004.
- 32 Boren J,Ramos-Montoya A,Bosch KS,Vreeling H,Jonker A,Centelles JJ,Cascante M,Frederiks WM. In situ localization of transketolase activity in epithelial cells of different rat tissues and subcellularly in liver parenchymal cells. J Histochem Cytochem 2006; 54: 191–9.
- 33 Jonker A,Geerts WJ,Charles R,Lamers WH,Van Noorden CJ. Image analysis and image processing as tools to measure initial rates of enzyme reactions in sections: distribution patterns of glutamate dehydrogenase activity in rat liver lobules. J Histochem Cytochem 1995; 43: 1027–34.
- 34 Vizan P,Alcarraz-Vizan G,Diaz-Moralli S,Rodriguez-Prados JC,Zanuy M,Centelles JJ,Jauregui O,Cascante M. Quantification of intracellular phosphorylated carbohydrates in HT29 human colon adenocarcinoma cell line using liquid chromatography-electrospray ionization tandem mass spectrometry. Anal Chem 2007; 79: 5000–5.
- 35 Lee WN,Boros LG,Puigjaner J,Bassilian S,Lim S,Cascante M. Mass isotopomer study of the nonoxidative pathways of the pentose cycle with [1,2-13C2]glucose. Am J Physiol 1998; 274: E843–51.
- 36 James J,Bosch KS,Fronik GM,Houtkooper JM. Naphthol-yellow-S protein content of individual rat hepatocytes as related to food intake and short-term starvation. Cell Tissue Res 1986; 243: 165–9.
- 37 Meek ES,Harbison JF. Nuclear area and deoxyribonucleic acid content in human liver cell nuclei. J Anat 1967; 101: 487–9.
- 38 Pardee AB. A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci USA 1974; 71: 1286–90.
- 39 Holley RW,Kiernan JA. Control of the initiation of DNA synthesis in 3T3 cells: low-molecular weight nutrients. Proc Natl Acad Sci USA 1974; 71: 2942–5.
- 40 Nelson DL,Cox MM. Lehninger principles of biochemistry. Gordonsville, VA: W. H. Freeman, 2004.
- 41 Boros LG,Cascante M,Paul Lee W-N. Metabolic profiling of cell growth and death in cancer: applications in drug discovery. Drug Discov Today 2002; 7: 364–72.
- 42 Jain M,Cui L,Brenner DA,Wang B,Handy DE,Leopold JA,Loscalzo J,Apstein CS,Liao R. Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase. Circulation 2004; 109: 898–903.
- 43 Stanton RC,Seifter JL,Boxer DC,Zimmerman E,Cantley LC. Rapid release of bound glucose-6-phosphate dehydrogenase by growth factors. Correlation with increased enzymatic activity. J Biol Chem 1991; 266: 12442–8.
- 44 Zhang Z,Apse K,Pang J,Stanton RC. High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. J Biol Chem 2000; 275: 40042–7.
- 45 Tian WN,Braunstein LD,Apse K,Pang J,Rose M,Tian X,Stanton RC. Importance of glucose-6-phosphate dehydrogenase activity in cell death. Am J Physiol 1999; 276: C1121–31.
- 46 Hammes HP,Du X,Edelstein D,Taguchi T,Matsumura T,Ju Q,Lin J,Bierhaus A,Nawroth P,Hannak D,Neumaier M,Bergfeld R, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 2003; 9: 294–9.
- 47 McCool BA,Plonk SG,Martin PR,Singleton CK. Cloning of human transketolase cDNAs and comparison of the nucleotide sequence of the coding region in Wernicke-Korsakoff and non-Wernicke-Korsakoff individuals. J Biol Chem 1993; 268: 1397–404.
- 48 Kabashima T,Kawaguchi T,Wadzinski BE,Uyeda K. Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci USA 2003; 100: 5107–12.
- 49 Uyeda K,Yamashita H,Kawaguchi T. Carbohydrate responsive element-binding protein (ChREBP): a key regulator of glucose metabolism and fat storage. Biochem Pharmacol 2002; 63: 2075–80.
- 50 Jiang Y. Regulation of the cell cycle by protein phosphatase 2A in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 2006; 70: 440–9.
- 51 Frederiks WM,Vizan P,Bosch KS,Vreeling-Sindelarova H,Boren J,Cascante M. Elevated activity of the oxidative and non-oxidative pentose phosphate pathway in (pre)neoplastic lesions in rat liver. Int J Exp Pathol 2008; 89: 232–40.
- 52 Havens CG,Ho A,Yoshioka N,Dowdy SF. Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen species. Mol Cell Biol 2006; 26: 4701–11.